Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

354 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term effectiveness and tolerability of apremilast in patients with moderate-to-severe plaque psoriasis: A 5-year multicentre retrospective study-IL PSO (Italian landscape psoriasis).
Gargiulo L, Ibba L, Malagoli P, Amoruso F, Balato A, Bardazzi F, Burlando M, Carrera CG, Dapavo P, Dini V, Gaiani FM, Girolomoni G, Guarneri C, Lasagni C, Loconsole F, Marzano AV, Maurelli M, Megna M, Travaglini M, Costanzo A, Narcisi A. Gargiulo L, et al. Among authors: bardazzi f. J Eur Acad Dermatol Venereol. 2024 Mar 29. doi: 10.1111/jdv.20003. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38553873 No abstract available.
The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic Patients.
Colombo D, Banfi G, Cassano N, Graziottin A, Vena GA, Fiori GG, Zagni E, Stingeni L, Chimenti S, Berardesca E, Micali G, Albertini G, De Simone C, Bellia G; GENDER ATTENTION study group. Colombo D, et al. Adv Ther. 2017 Jun;34(6):1349-1363. doi: 10.1007/s12325-017-0526-7. Epub 2017 Apr 21. Adv Ther. 2017. PMID: 28432647 Free PMC article.
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study-IL PSO (Italian Landscape Psoriasis).
Valenti M, Gargiulo L, Ibba L, Malagoli P, Amoruso F, Balato A, Bardazzi F, Burlando M, Carrera CG, Dapavo P, Dini V, Gaiani FM, Girolomoni G, Guarneri C, Lasagni C, Loconsole F, Marzano AV, Maurelli M, Megna M, Orsini D, Travaglini M, Costanzo A, Narcisi A. Valenti M, et al. Among authors: bardazzi f. Dermatol Ther (Heidelb). 2024 May 15. doi: 10.1007/s13555-024-01182-4. Online ahead of print. Dermatol Ther (Heidelb). 2024. PMID: 38748344
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study - IL PSO (Italian landscape psoriasis).
Gargiulo L, Ibba L, Cascio Ingurgio R, Malagoli P, Amoruso F, Balato A, Bardazzi F, Brianti P, Brunasso G, Burlando M, Cagni AE, Caproni M, Carrera CG, Carugno A, Caudullo F, Cuccia A, Dapavo P, Di Brizzi EV, Dini V, Gaiani FM, Gisondi P, Guarneri C, Lasagni C, Licata G, Loconsole F, Marzano AV, Megna M, Mercuri SR, Musumeci ML, Orsini D, Ribero S, Ruffo Di Calabria V, Satolli F, Strippoli D, Travaglini M, Trovato E, Venturini M, Zichichi L, Valenti M, Costanzo A, Narcisi A. Gargiulo L, et al. Among authors: bardazzi f. J Dermatolog Treat. 2024 Dec;35(1):2350760. doi: 10.1080/09546634.2024.2350760. Epub 2024 May 7. J Dermatolog Treat. 2024. PMID: 38714323 Free article.
Mehr als nur Lipome?: More than mere lipomas?
Bardazzi F, Starace M, Loi C, Filippi F, Peron I, Sacchelli L. Bardazzi F, et al. J Dtsch Dermatol Ges. 2024 Apr;22(4):601-603. doi: 10.1111/ddg.15362_g. J Dtsch Dermatol Ges. 2024. PMID: 38574030 German. No abstract available.
More than mere lipomas?
Bardazzi F, Starace M, Loi C, Filippi F, Peron I, Sacchelli L. Bardazzi F, et al. J Dtsch Dermatol Ges. 2024 Apr;22(4):601-603. doi: 10.1111/ddg.15362. Epub 2024 Mar 20. J Dtsch Dermatol Ges. 2024. PMID: 38506609 No abstract available.
354 results